Vaxxinity Incorporated develops products in the fields of neurology and coronaviruses in the U.S. Its pipeline includes UB-311, in Phase 2 clinical trials to treat Alzheimer's disease, UB-312 to treat Parkinson's disease, and UB-612, in Phase 3 clinical trials to neutralize the SARS-CoV-2 virus. The company was founded in 2014 and is headquartered in Dallas, TX.
What is Vaxxinity's quote symbol?
What is the 52 week high and low for Vaxxinity (NASDAQ: VAXX)?
How much is Vaxxinity stock worth today?
How much is Vaxxinity's stock price per share?
What is Vaxxinity's Market Cap?